Deal Watch: Lilly Turns To Oblique For Antibody Discovery

Firm Also Expands Emgality Commercialization Pact With Organon

23 Aug 2024

Plus deals involving Lilly/Oblique, Rafael Holdings/Cyclo, ADCendo/Multitude, Ocuvex/Visiox and more.